You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 11, November 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Juvenile Linear Scleroderma Associated With Serologic Abnormalities

Thomas Y. Woo, MD; James E. Rasmussen, MD

Arch Dermatol. 1985;121(11):1403-1405.


Abstract

• We investigated 24 juvenile cases of linear scleroderma for the presence of systemic disease and serologic abnormalities. Thirteen of 24 patients had antinuclear antibodies (ANA) at titers of 1:40 or greater. Rheumatoid factor (titers ≥1:20) was detected in seven of 17 patients tested, five of whom also had ANA. Two of five patients with ANA and rheumatoid factor had systemic diseases, such as nephritis and Raynaud's phenomenon. One patient with ANA developed typical dermatomyositis. Consequently, patients with linear scleroderma may be at some risk for developing systemic collagen-vascular diseases. On initial presentation, patients with linear scleroderma should give a complete history and receive a thorough physical examination as well as undergo laboratory evaluations for the presence of ANA and rheumatoid factor. Long-term observation with periodic reevaluation is appropriate for many members of this group.

(Arch Dermatol 1985;121:1403-1405)



Author Affiliations

From the Department of Internal Medicine, University of Calgary, Alberta (Dr Woo), and the Department of Dermatology, University of Michigan Medical Center, Ann Arbor (Dr Rasmussen).


Footnotes

Accepted for publication June 25, 1985.

Reprint requests to Department of Dermatology, C2069 Outpatient Bldg, Box 031, Ann Arbor, MI 48109-0010 (Dr Rasmussen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma
Yamane et al.
Rheumatology (Oxford) 2001;40:683-686.
ABSTRACT | FULL TEXT  

Prevalence and Characteristics of Anti--Single-Stranded DNA Antibodies in Localized Scleroderma: Comparison With Systemic Lupus Erythematosus
Ruffatti et al.
Arch Dermatol 1991;127:1180-1183.
ABSTRACT  

Antinuclear and Anti-Single-Stranded DNA Antibodies in Morphea and Generalized Morphea
Falanga et al.
Arch Dermatol 1987;123:350-353.
ABSTRACT  

Immunologic Abnormalities in Linear Scleroderma
Vazquez et al.
Arch Dermatol 1986;122:623-624.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.